Sorkin A, Mazzotti M, Sorkina T, Scotto L, Beguinot L
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
J Biol Chem. 1996 Jun 7;271(23):13377-84. doi: 10.1074/jbc.271.23.13377.
The carboxyl-terminal regulatory domain of the epidermal growth factor (EGF) receptor is essential for its endocytosis and interaction with the clathrin-associated protein complex AP-2. To identify AP-2 binding motif in the receptor, several single and multiple-point mutations within the region between residues 966 and 977 of the human EGF receptor were made, and the mutant receptors were expressed in NIH3T3 cells. Mutation of tyrosine 974 alone or together with surrounding residues and the deletion of residues 973-975 essentially eliminated AP-2 co-immunoprecipitation with the EGF receptor. Furthermore, a synthetic peptide corresponding to receptor residues 964-978 blocked AP-2 association with the wild-type EGF receptor. These data suggest that AP-2 has only one high-affinity binding site in the EGF receptor composed of Tyr974-containing motif. Receptor mutants that did not bind AP-2 displayed a lower rate of internalization, down-regulation, and turnover compared to wild-type receptors when expressed at high levels. However, similar receptor mutants expressed at low levels were internalized and down-regulated as efficiently as wild-type receptors. Internalization of the mutant receptors lacking the high-affinity binding site for AP-2 was inhibited by K+-depletion of the cells, indicating that their endocytosis required intact coated pits. We suggest that whereas one mechanism of EGF receptor recruitment into coated pits involves high-affinity binding of AP-2 to Tyr974-containing motif, another pathway may be mediated by weak receptor/AP-2 interactions or by proteins other than AP-2.
表皮生长因子(EGF)受体的羧基末端调节结构域对其胞吞作用以及与网格蛋白相关蛋白复合物AP-2的相互作用至关重要。为了鉴定该受体中的AP-2结合基序,在人EGF受体第966至977位残基之间的区域内进行了几个单点和多点突变,并在NIH3T3细胞中表达了突变受体。单独突变酪氨酸974或与周围残基一起突变以及缺失残基973 - 975基本上消除了AP-2与EGF受体的共免疫沉淀。此外,一段对应于受体第964 - 978位残基的合成肽阻断了AP-2与野生型EGF受体的结合。这些数据表明,AP-2在EGF受体中只有一个由含Tyr974基序组成的高亲和力结合位点。与野生型受体相比,不结合AP-2的受体突变体在高水平表达时内化、下调和周转的速率较低。然而,低水平表达的类似受体突变体与野生型受体一样有效地被内化和下调。缺乏AP-2高亲和力结合位点的突变受体的内化受到细胞K⁺耗竭的抑制,表明它们的胞吞作用需要完整的被膜小窝。我们认为,虽然EGF受体募集到被膜小窝的一种机制涉及AP-2与含Tyr974基序的高亲和力结合,但另一条途径可能由受体/AP-2的弱相互作用或由AP-2以外的蛋白质介导。